Consent
Settings
Cookie information
Cookie information

We use cookies to customize content and ads and to analyze access to our website. In addition, we share information about your use of our website with our analytics partners. Our partners may combine this information with other data that you have provided to them or that they have collected in the course of your use of their services.

Cookie settings
  • Essential 3

    Essential cookies help make a website user-friendly by enabling basic functions such as page navigation and access to secure areas of the website. Without these cookies, the website cannot function properly.

    Cookie declaration
    Name Provider Purpose Expiration date
    accepted_cookies kinaselogistics.com Stores the status of the visitor's consent for cookies of the current domain. 1 year
    accepted_cookie_types kinaselogistics.com Stores the type of cookies that the visitor has agreed to for the current domain. 1 year
    __cf_bm myfonts.net This website uses a web font from myfonts.com or hello.myfonts.net. The cookie is used to comply with the licensing terms for the use of this font style. In doing so, visits to the website are recorded for statistical purposes and transmitted to Monotype Imaging Holdings Inc, 600 Unicorn Park Drive, Woburn, MA 01801, USA. 1 year
  • stats 3

    Statistical cookies help website owners understand user behavior on their websites by collecting and reporting anonymous information. This allows them to understand how visitors interact with the web pages.

    Cookie declaration
    Name Provider Purpose Expiration date
    MATOMO_SESSID matomo.org This cookie is placed by the statistics/analysis tool Matomo (formerly Piwik). It provides the function to disable or enable Matomo. If the user chooses to disable or enable, other cookies (mtm_consent, mtm_consent_removed, mtm_cookie_consent or piwik_ignore) are set by Matomo to store whether tracking should occur. 14 days
    _pk_id.1.2494 matomo.org This cookie is placed by the statistics/analysis tool Matomo (formerly Piwik). It is used to store some details about the user, such as the unique visitor ID. 13 months
    _pk_ses.1.2494 matomo.org This cookie is placed by the statistics/analysis tool Matomo (formerly Piwik). It is used to store some details about the user, such as the unique visitor ID. 30 minutes
About cookies on this website

Cookies are small text files used by websites to make the user experience more efficient.

In accordance with applicable law, we store necessary cookies on your device, as they are essential for the operation of this site. For all other cookie types, we need your consent. Necessary cookies are processed pursuant to Article 6(1)(f) DSGVO, while other cookies, such as preference and marketing cookies, are processed on the basis of Article 6(1)(a) DSGVO.

This website uses various types of cookies, including those from third-party providers.

You can change or revoke your consent at any time in the cookie declaration on our website.

For more information about our identity, contact details and processing of personal data, please see our Privacy Policy.

Confirm selection
Confirm all

Newsroom
Find our latest news

News

  • Cancer treatments using inhibitors of CDK, a cell cycle regulator Newsletter

    Cancer treatments using inhibitors of CDK, a cell cycle regulator

    Carna Newsletter Vol.16

    Read more
  • ALK drug resistant mutations: Challenges for the treatment of lung cancer Newsletter

    ALK drug resistant mutations: Challenges for the treatment of lung cancer

    Carna Newsletter Vol.15 

     

    Read more
  • 2023 Year-End Campaign Offers

    2023 Year-End Campaign

    We’ve got good news for you: a special discount for human Kinases from Carna Biosciences.

    Read more
  • DGKα and DGKζ are key targets for cancer immunotherapy Technical Note

    DGKα and DGKζ are key targets for cancer immunotherapy

    Carna Newsletter Vol.14

    Read more
  • The potential of PIKfyve inhibitor as a treatment of amyotrophic lateral sclerosis (ALS) Newsletter

    The potential of PIKfyve inhibitor as a treatment of amyotrophic lateral sclerosis (ALS)

    Carna Newsletter Vol.13

    Read more
  • New Cellular CDK Assay Panel Launched and Special Offers from Carna Offers

    New Cellular CDK Assay Panel Launched and Special Offers from Carna

    We are pleased to launch a new CDK (cyclin-dependent kinases) Cell-based Assay Panel for kinase researchers who are focusing on the CDK family.

    …
    Read more
Scientist typing on Laptop

Newsletter

Newsletter abonnieren Icon
Contact us